This Action addresses the problem of synthesizing and optimizing NP to meet the physicochemical requirements of drug discovery and the challenging problem of finding new lead structures of therapeutic relevance. This COST Action aims at innovatively exploiting NP chemistry to boost the drug discovery-oriented pipeline by combining academic research with industrial needs. The research aim of the Action is to identify NP leads candidates by sharing and disseminating the knowledge present in individual research groups in Europe.